您的位置: 首页 > 农业专利 > 详情页

Oxaborole esters and uses thereof
专利权人:
ANACOR PHARMACEUTICALS INC.
发明人:
Akama, Tsutomu,Carter, David Scott,Halladay, Jason S.,Jacobs, Robert T.,Liu, Yang,Plattner, Jacob J.,Zhang, Yong-Kang,Witty, Michael John
申请号:
NZ74850217
公开号:
NZ748502A
申请日:
2017.05.01
申请国别(地区):
NZ
年份:
2020
代理人:
摘要:
Trypanosomatids are a group of kinetoplastid protozoa distinguished by having only a single flagellum. Trypanosomatids are responsible for diseases such as South American trypanosomiasis (Chagas Disease) and African Animal Trypanosomosis (AAT). Trypanosomosis has a major economic impact on cattle production in Africa and, if untreated, generally results in chronic illness with high mortality. In the absence of vaccines, control of this disease has for long been focused on chemotherapy and vector control. The present invention provides certain oxaborole ester compounds and compositions thereof which are useful to treat diseases associated with parasites, such as African Animal Trypanosomosis. In particular, the present invention provides a compound selected from the group consisting of: (6-(Trifluoromethyl)pyridin-3-yl)methyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-L-valinate; 4-Fluorobenzyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-L-valinate; and, 4,4- Difluorocyclohexyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-L-valinate; Tetrahydro-2H-pyran-4-yl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-L-valinate; and, a pharmaceutically acceptable salt thereof. Also provided is the use of a compound selected from the group consisting of: (6-(Trifluoromethyl)pyridin-3-yl)methyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-L-valinate; 4-Fluorobenzyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-L-valinate; and, 4,4- Difluorocyclohexyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-L-valinate; Tetrahydro-2H-pyran-4-yl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-L-valinate; and, a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating a parasitic infection in a subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充